Stay updated with breaking news from Trauma Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- HemoSonics, LLC, a leading medical device company delivering individualized diagnostic solutions for Patient Blood Management (PBM), announced...
/PRNewswire/ -- NeuroTrauma Sciences, LLC (NTS), a private biopharmaceutical company developing a portfolio of disease-modifying therapeutic candidates to...
Share this article Share this article ATLANTA, May 11, 2021 /PRNewswire/ -- NeuroTrauma Sciences, LLC (NTS), a private biopharmaceutical company developing a portfolio of disease-modifying therapeutic candidates to treat the devastating effects of acquired brain injury, today announced it has entered into a research collaboration with Antwerp University Hospital, Belgium, to help support "Collaborative European NeuroTrauma Effectiveness Research in TBI" (CENTER-TBI), a prospective longitudinal observational study that is collecting clinical and epidemiological data to identify the most effe...